A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Clinical trial NCT07209449 · RECRUITING
Trial details
- NCT number
- NCT07209449
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-10-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.